This Article contains errors in the Reference list. Reference 33 is incorrectly listed as reference 26 and references 26–32 are incorrectly listed as references 27–33 respectively. The correct references are listed below:
26 Zhang, J. et al. Nuclear localization of Cdk5 is a key determinant in the postmitotic state of neurons. Proc. Natl. Acad. Sci. USA 105, 8772–8777 (2008).
27 Liang, Z. et al. Cdk5 regulates activity-dependent gene expression and dendrite development. J. Neurosci. 35, 15127–15134 (2015).
28 Ino, H. & Chiba, T. Intracellular localization of cyclin-dependent kinase 5 (CDK5) in mouse neuron: CDK5 is located in both nucleus and cytoplasm. Brain Res. 732, 179–185 (1996).
29 Asada, A. et al. Myristoylation of p39 and p35 is a determinant of cytoplasmic or nuclear localization of active cyclin-dependent kinase 5 complexes. J. Neurochem. 106, 1325–1336 (2008).
30 Asada, A., Saito, T. & Hisanaga, S. Phosphorylation of p35 and p39 by Cdk5 determines the subcellular location of the holokinase in a phosphorylation-site-specific manner. J. Cell Sci. 125, 421–3429 (2012).
31 Saito, T. et al. p25/cyclin-dependent kinase 5 promotes the progression of cell death in nucleus of endoplasmic reticulum-stressed neurons. J. Neurochem. 102, 133–140 (2007).
32 Hagmann, H. et al. Cyclin I and p35 determine the subcellular distribution of Cdk5. Am. J. Physiol. Cell Physiol. 308, C339–347 (2015).
33 Xue, Y. et al. GPS 2.1: enhanced prediction of kinase-specific phosphorylation sites with an algorithm of motif length selection. Protein Eng. Des. Sel. 24, 255–260 (2011).
In the Discussion section under “CCNI2 regulates cell cycle”, the references following the sentence “Several groups showed independently that CDK5 could regulate cell cycle26,27,34–37”
Should read:
“Several groups showed independently that CDK5 could regulate cell cycle26,34–37”.
Additional information
The online version of the original article can be found at 10.1038/srep40979
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Liu, C., Zhai, X., Zhao, B. et al. Erratum: Cyclin I-like (CCNI2) is a cyclin-dependent kinase 5 (CDK5) activator and is involved in cell cycle regulation. Sci Rep 7, 44164 (2017). https://doi.org/10.1038/srep44164
Published:
DOI: https://doi.org/10.1038/srep44164
This article is cited by
-
CCNI2 promotes the progression of human gastric cancer through HDGF
Cancer Cell International (2021)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
